Live Webinar | hfma:content/topic/physician_paymentandreimbursement
Save
Live Webinar | Finance and Business Strategy
Save
Live Webinar | Costing and Managerial Accounting
Save
Comment Letter | Pricing

HFMA Comments on the Senate Transparency Initiative

Comment Letter | Pricing

HFMA Comments on the Senate Transparency Initiative

HFMA provides comments to Senators to inform the bipartisan initiative to increase healthcare price and quality transparency, as described in a February 28, 2018, letter.

The Healthcare Financial Management Association (HFMA) would like to thank you for the opportunity to provide comments to inform the bipartisan initiative to increase healthcare price and quality transparency, as described in your letter of February 28, 2018.

In 2014, HFMA convened a multi-stakeholder task force charged with reaching consensus on how consumers can obtain clear and easy-to-understand healthcare price and quality information in a timely fashion. The recommendations that emerged from this task force were published in Price Transparency in Health Care: Report from the HFMA Price Transparency Task Force . The comments submitted here are grounded in the industry-consensus recommendations found in that report, along with the Patient Financial Communications Best Practices , which were developed with the guidance of a multi-stakeholder steering committee convened by HFMA.

The questions posed in your letter of February 28 are reprinted below, followed by HFMA’s responses.

Download the comment letter

Sign up for a free guest account and get access to five free articles every month.

Advertisements

Related Articles | Pricing

Blog | Medicare Payment and Reimbursement

Research examines whether financial challenges facing hospitals with large Medicare populations lead indirectly to cost shifting

Harvard researchers found evidence to suggest that hospitals with large shares of Medicare patients are at greater risk of being acquired, which can skew the market structure and lead to higher commercial prices.

Blog | Contracting

Study: In price negotiations with hospitals, self-insured employers lack leverage

The vast difference in market power between hospitals and employers leaves the latter group with little recourse in negotiations, according to a new study.

How To | Cost Effectiveness of Health

Moving a 340B covered entity’s pharmacy enterprise to an LLC may prove beneficial, but it requires a feasibility study

University of Utah Hospitals and Clinics (UUHC) in Salt Lake City performed research to assess the feasibility of moving its 340B covered-entity pharmacy enterprise to a Limited Liability Corporation (LLC), with a focus on risks that should be factored into the decision. Other organizations that are considering such a move could benefit from adopting UUHC’s assessment approach.

News | Price Transparency

Congress seeks stepped-up hospital price transparency enforcement as compliance issues continue to emerge

The bipartisan leadership of a congressional committee is urging HHS to enforce price transparency rules more stringently.